Newly released documents add vivid detail to the emerging portrait of the Food and Drug Administration’s ineffective and halting efforts to regulate a Massachusetts company implicated in a nationalmeningitis outbreak that has sickened nearly 500 people and killed 34.
 
Continue reading here